A complete application in a minute
Tailored resume and cover letter, ready to send.
Skin Analytics Ltd is seeking a Business Development Manager - EU to drive new business outside the UK, targeting insurers, hospital groups, clinics, and regulated retailers. The role focuses on expanding in Europe where regulatory clearance exists, with an uncapped commission structure.
You will lead end-to-end sales, own the pipeline, and collaborate with teams to onboard new clients while representing the company at industry events.
The Business Development Manager - EU role is responsible for identifying, pursuing, and securing new business opportunities outside of the UK, targeting Private Medical Insurers, (Private) Hospital groups, Dermatology Clinics, and Regulated Retail environments. This role focuses on expanding the company's presence in Europe and other regions where we have regulatory clearance (excluding the US). This role qualifies for an uncapped commission structure.
Building a Strong Foundation Always Learning Lead from the Front Tough and ResilientThe Real Stuff
Skin Analytics embraces and is committed to diversity and equal opportunities. We are dedicated to building a team that represents a variety of backgrounds, perspectives, and skills. The more inclusive we are, the better our work will be. If you need any adjustments during our hiring process, you can indicate that at the next step.
AI usage in our hiring process: If you submit an application to us, you will consent to AI playing a role in your hiring process. No hiring decision is ever made by an algorithm alone. Every AI-generated summary, screening result, or note is reviewed, verified, and, if necessary, corrected by a member of our recruitment team. Humans make the final call on who moves forward and who receives an offer. You can find more information about how we use AI in our hiring process here.
LocationLondon hybrid (3 days in office)AddressLondon, EnglandEmployment TypeFull timeLocation TypeHybridDepartmentCommercialSales
Skin Analytics is an award-winning, health tech company that deploys world-leading skin cancer pathways using AI as a medical device, DERM. Following our recent 15M series B funding, regulatory milestones hit, and doubling from 50 to 100 headcount in 2025, we're ready to scale further internationally, making history for AI in healthcare and the future of 're proud to epitomise AI for good - with a Class III CE mark, DERM is the only AI as a medical device approved to make clinical decisions autonomously in the cancer space, as well as being the first company to receive a NICE recommendation for use across the NHS.